Plexus Electronica S. de R.L. de C.V. – FDA 483, Nov 26, 2018

The provided document is a generic preamble to an FDA Form 483, outlining the regulatory basis for observations made during an inspection. It references Section 704(b) of the Federal Food, Drug and Cosmetic Act, which mandates reporting objectionable conditions or practices observed. This section specifies that conditions indicating a product is filthy, putrid, decomposed, or prepared/held under insanitary conditions must be reported to the firm's owner, operator, or agent in charge, with a copy sent to the Secretary. The document explains that 483 observations are reported either pursuant to this section or to assist firms in complying with regulations. However, the provided text does not contain any specific details regarding a company name, inspection dates, main violations, or required actions for a particular inspection. It is a boilerplate explanation of the FDA 483 form's purpose and legal framework.